Clinical Criteria for a Pathogen in Term Newborn Suspected of Neonatal Sepsis
NCT ID: NCT03623503
Last Updated: 2018-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
58 participants
OBSERVATIONAL
2016-02-21
2017-07-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes and Predictors of Mortality Among Preterm Infants With Neonatal Sepsis
NCT06113653
Serum Presepsin as Early Predictor for Neonatal Early-onset Sepsis
NCT05022043
Predictors of Sepsis in Ex-Preterm Infants
NCT03433846
Comparison of Peripheral Perfusion Level Between Two Groups of Newborns According to Their Infectious Status Defined by the Criteria of the Center for Disease Control and Prevention (CDC)
NCT03117907
An Audit Study on Management of Neonates With Neonatal Sepsis Admitted to Asyut University Children Hospital
NCT03634891
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
first group
Observational study of 25 newborn with a likely EOS
Observational study
second group
Observational study of v33 newborn with a possible EOS
Observational study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Day
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre Tourneux, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU AMIENS
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RNI2016-18- PrTourneux
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.